Early changes preceding beta cell autoimmunity and type 1 diabetes
Bidragets beskrivning
Type 1 diabetes (T1D) is heterogeneous autoimmune disease that has high prevalence in developed countries. It has severe long-term complications and constitutes a significant challenge to the health care system. Our goal is to improve understanding of disease process by studying changes in immune cells during early stages of disease development. Further, we aim at discovering and validating these changes that could potentially be used to predict, diagnose and monitor T1D. We will combine expertise and methods from different disciplines including clinical research, cutting-edge experimental methods and computational systems biology. Our results are expected to increase understanding of the pathogenesis of human T1D and immune response early in the disease process. We expect to discover and validate candidate biomarkers that identify individuals with risk to develop T1D, which in turn will provide new opportunities for early prevention and treatment of the disease.
Visa merStartår
2021
Slutår
2022
Beviljade finansiering
Finansiär
Finlands Akademi
Typ av finansiering
Forskardoktorer
Utlysning
Övriga uppgifter
Finansieringsbeslutets nummer
340231
Vetenskapsområden
Genetik, utvecklingsbiologi, fysiologi
Forskningsområden
Perinnöllisyystiede
Identifierade teman
diabetes, medicine, metabolic diseases